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PARTICLES CAN BE ENGINEERED TO NANOME-
ter-size (nm) which are only 1/1,000 the
width of a single human hair. Nanopar-
ticies made of gold display strong optical
absorption.' A special type of gold nano-
particle called hollow gold nanoparticle
has a core-shell nanostructure with unique
characteristics, including small particle
size ("40 nm in diametet), which is an
ideal range for particles to be incorporated
into living cells; hollow interior, which
allows for higher drug loading capacity;
and pure gold composition, which is as-
sociated with less toxicity.^ ' ' The hollow
gold nanoparticies have been proven to
convert optical energy into thermal en-
ergy, leading to overheating of the local
environment around the light-absorbing
species. This phenomenon is known as
photothermal effect."* We have developed
a variety of applications of hollow gold
nanoparticies in cancer diagnosis and
therapeutics, including photothermal
ablation therapy, photoacoustic tomogra-
phy, and light-controlled drug release.
PHOTOTHERMAL ABLATION THERAPY
Photothermal ablation therapy is a
therapeutic modality iti which the light-
absorbing nanoparticies are utilized to
burn the tumor cells.^  The heat produced
can lead to localized temperatures far above
the threshold temperature (-330 K) that
causes irreversible cell death.'' By vary-
ing the core radius and shell thickness,
the optical absorption of hollow gold
nanoparticies can be fine-tuned to the
near-infrared (NIR) region.^  Absorbance
of NIR light is desirable because it causes
minimal thermal injury to normal tissues
and deeper tissue penetration, to several
centimeters.^ We have applied this so
called "targeted delivery" technology in
order to increase the nanoparticies' ability
to enter the cancerous cells. In a mouse-
bearing melanoma model, the surface
of hollow gold nanoparticies was coated
with small peptide NDP-MSH, a potent
agonist of melanocortin type-1 receptor,
which is overexpressed in melanoma
cells.* Following intravenous injection the
NDP-MSH modified nanoparticies were
actively located and drawn into cancer
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cells through the cell membrane. NIR
light beamed into tumors with targeted
nanoparticies destroyed 66 percent ofthe
tumors, but only destroyed 8 percent of
tumors treated with untargeted nanopar-
ticies." (Figure 1) Because ofthe specific
accumulation of nanoparticies in tumor
but not in normal tissues, the efficiency of
photothermal ablation therapy was vastly
improved and side effects were reduced
by decreasing the laser dose duration and
volume.
PHOTOACOUSTIC TOMOGRAPHY
Photoacoustic tomography is a hy-
brid technology that visualizes the internal
distribution of optical energy deposition
in biological tissues through the detection
of laser-induced ultrasonic waves.'' Pho-
toacoustic tomography provides higher
spatial resolution than traditional optical
imaging in deep biological tissues because
ultrasonic scattering in such tissues is two
orders of magnitude less than optical scat-
tering. The hollow gold nanoparticies can
increase photoacoustic signals because of
their light excitation in the NIR spectral
region, where the signal ratio of gold
nanoparticies to hemoglobin is high and
contrast to endogenous chromophores is
great.'" Recently, we developed peptide-
based hollow gold nanoparticies to target
integrins that are overexpressed in both
glioma and angiogenic tumor blood
vessels. The targeted nanoparticies per-
mitted accurate photoacoustic imaging
of inoculated U87 glioma in nude mice
and mediated selective antitumor effect
when mice were irradiated with an NIR
laser." These findings suggest potential
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Figure 1. Photothermal ablation with targeted hollovi' gold nanoparticle-induced destruction
of B16/F10 melanoma in nude mice. H&E staining of tumor sections 24 h after NIR
laser irradiation. Tumor cells characterized by extensive pyknosis, karyolysis, cytoplasmic
acidophllia, and degradation ofthe extracellulat matrix ofthe tumor in mice treated with
targeted nanoparticies plus laser. In mice treated with non-targeted nanoparticies plus laser,
such features were observed mostly in areas close to the surface.
(Copyright American Association for Cancer Research. Reprinted with permission.)
applications of hollow gold nanoparticles
as a novel diagnostic and therapeutic
platform for 1) photoacoustic imaging
for pretreatment diagnosis, real-time
monitoring of treatment, as well as as-
sessment of treatment outcome; and 2)
photothermal ablation therapy of tumor
cells under the guidance of photoacoustic
imaging. Human malignant gliomas are
characterized by their ability to infiltrate
and invade surrounding normal brain
tissues. Complete tumor resection is
often limited by the surgeon's ability to
distinguish residual tumor tissue from
surrounding brain tissue. Tumors often
recur because it is extremely difficult to
remove infiltrating tumor cells without
affecting vital brain fijncrions. With this
technique, it may be possible to achieve
NIR laser treatment of the surgical bed
through optical fiber for the eradication
of residual brain tumor cells.
LIGHT-CONTROLLED DRUG RELEASE
The hollow gold nanoparticles can
also act as vehicles to get the cancer cells
to take the chemotherapy "bait". Because
of their hollow interior, each hollow
gold nanoparticle can load thousands of
chemotherapy "baits". The drug-loaded
nanoparticles are like a Trojan horse that
can efficiently ferry "toxins" to the tumor
cells. The hollow gold nanoparticles with
high photothermal conversion efficiency
can be exploited for controlled release
of doxorubicin from the particles using
NIR light as the external stimulus to
trigger drug release.'^  Results from both
cell and animal experiments showed that
NIR light triggered release of doxorubicin
from doxorubicin-loaded hollow gold
nanoparticles in tumor sites offered tem-
porally and spatially controlled release of
the chemotherapeutic agent.'^' ' ' This in-
creased the therapeutic efficacy and speci-
ficity. The nano-drug delivery system was
also found to alter the pharmacokinetic
disadvantages of the free drug, avoiding
a burst exposure of a large amount of
drug to vital organs such as the liver and
kidney. In a future study, we will use the
hollow gold nanoparticles to load the anti-
cancer drug cisplatin. Conjugated with
NDP-MSH peptide, the cisplatin-loaded
nanoparticles will target melanoma. The
combination of photothermal therapy
and chemotherapy, with laser controlled
drug release, may produce a synergistic
anticancer effect to overcome tumor
regrowth and cisplatin resistance.
In summary, nanomedicine with
hollow gold nanoparticles represents an
innovative field with immense potential
for improving cancer treatment. As il-
lustrated in animal models,*' '"' "' ' ' the
novel nano-drug delivery platforms have
shown several potential advantages such
as tumor targeting, optical imaging and
controlled release strategies. Nanomedi-
cine may generate a robust and efficacious
therapeutic modality.
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